Sona Nanotech Inc (TSE:SONA) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Sona Nanotech Inc. has awarded 25,000 stock options to a consultant, with a vested interest accruing every six months and an exercise price of $0.30 per share. Simultaneously, the company is advancing its innovative Targeted Hyperthermia cancer therapy, which employs gold nanoparticles for effective tumor treatment and is moving towards regulatory approvals.
For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.